Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Your prescriber uses your response at each dose level to determine when and whether to escalate
Early research suggests that people using GLP-1-based medications may have lower rates of certain cancers compared with similar patients who are not using them
GLP-1 RAs were identified in the DRUG files using generic or brand names, including exenatide (BYETTA, BYDUREON BCISE), liraglutide (VICTOZA, SAXENDA, XULTOPHY), lixisenatide (LYXUMIA, ADLYXIN, SOLIQUA), dulaglutide (TRULICITY), semaglutide (OZEMPIC, RYBELSUS, WEGOVY), and tirzepatide (MOUNJARO, ZEPBOUND)
Since tirzepatide may delay the digestion and absorption of some medications, including oral contraceptives, unexpected bleeding should be reported to a provider to rule out possible interactions
